RU2017102513A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017102513A3 RU2017102513A3 RU2017102513A RU2017102513A RU2017102513A3 RU 2017102513 A3 RU2017102513 A3 RU 2017102513A3 RU 2017102513 A RU2017102513 A RU 2017102513A RU 2017102513 A RU2017102513 A RU 2017102513A RU 2017102513 A3 RU2017102513 A3 RU 2017102513A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014132413 | 2014-06-27 | ||
| JP2014-132413 | 2014-06-27 | ||
| PCT/JP2015/068575 WO2015199234A1 (ja) | 2014-06-27 | 2015-06-26 | ハロゲン置換へテロ環化合物の塩 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017102513A RU2017102513A (ru) | 2018-07-27 |
| RU2017102513A3 true RU2017102513A3 (ru) | 2018-12-11 |
| RU2689315C2 RU2689315C2 (ru) | 2019-05-27 |
Family
ID=54938311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017102513A RU2689315C2 (ru) | 2014-06-27 | 2015-06-26 | Соль гетероциклического соединения, замещенного галогеном |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10023554B2 (ru) |
| EP (1) | EP3162801B1 (ru) |
| JP (1) | JP6579103B2 (ru) |
| KR (1) | KR102433588B1 (ru) |
| CN (1) | CN106458964B (ru) |
| AU (1) | AU2015281021B9 (ru) |
| CA (1) | CA2953472C (ru) |
| ES (1) | ES2824801T3 (ru) |
| MX (1) | MX370408B (ru) |
| RU (1) | RU2689315C2 (ru) |
| WO (1) | WO2015199234A1 (ru) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2906931C (en) | 2013-03-15 | 2023-03-14 | Epigen Biosciences, Inc. | Heterocyclic compounds useful in the treatment of disease |
| CA3005811A1 (en) * | 2015-11-20 | 2017-05-26 | Ube Industries, Ltd. | Pharmaceutical composition for treatment or prevention of nash |
| JP7173350B2 (ja) * | 2019-07-30 | 2022-11-16 | 大正製薬株式会社 | Ｌｐａ１受容体を拮抗するウレア化合物 |
| CA3158743A1 (en) | 2019-11-15 | 2021-05-20 | Gilead Sciences, Inc. | Triazole carbamate pyridyl sulfonamides as lpa receptor antagonists and uses thereof |
| TWI843503B (zh) | 2020-06-03 | 2024-05-21 | 美商基利科學股份有限公司 | Lpa受體拮抗劑及其用途 |
| US11702407B2 (en) | 2020-06-03 | 2023-07-18 | Gilead Sciences, Inc. | LPA receptor antagonists and uses thereof |
| US11980609B2 (en) | 2021-05-11 | 2024-05-14 | Gilead Sciences, Inc. | LPA receptor antagonists and uses thereof |
| WO2023107938A1 (en) | 2021-12-08 | 2023-06-15 | Gilead Sciences, Inc. | Lpa receptor antagonists and uses thereof |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1258484T3 (da) | 2000-02-18 | 2009-04-20 | Kyowa Hakko Kirin Co Ltd | Nye isoxazol- og thiazolforbindelser og anvendelse deraf som lægemidler |
| WO2002062389A1 (fr) | 2001-02-08 | 2002-08-15 | Ono Pharmaceutical Co., Ltd. | Remedes pour des maladies urinaires contenant des agents de regulation du recepteur de lpa |
| JP4692281B2 (ja) | 2003-08-05 | 2011-06-01 | 味の素株式会社 | 新規アゾール化合物 |
| GB2466121B (en) | 2008-12-15 | 2010-12-08 | Amira Pharmaceuticals Inc | Antagonists of lysophosphatidic acid receptors |
| GB2470833B (en) | 2009-06-03 | 2011-06-01 | Amira Pharmaceuticals Inc | Polycyclic antagonists of lysophosphatidic acid receptors |
| EP2462128B1 (en) | 2009-08-04 | 2016-09-21 | Amira Pharmaceuticals, Inc. | Compounds as lysophosphatidic acid receptor antagonists |
| GB2474748B (en) | 2009-10-01 | 2011-10-12 | Amira Pharmaceuticals Inc | Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| GB2474120B (en) | 2009-10-01 | 2011-12-21 | Amira Pharmaceuticals Inc | Compounds as Lysophosphatidic acid receptor antagonists |
| WO2011091167A2 (en) | 2010-01-22 | 2011-07-28 | The General Hospital Corporation | Lysophosphatidic acid receptor targeting for scleroderma and other fibrotic diseases |
| WO2011159633A1 (en) | 2010-06-15 | 2011-12-22 | Amira Pharmaceuticals, Inc. | Inhalable formulations of lysophosphatdic acid receptor antagonists |
| US20130253019A1 (en) | 2010-06-15 | 2013-09-26 | John Howard Hutchinson | Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye |
| WO2011159635A1 (en) | 2010-06-15 | 2011-12-22 | Amira Pharmaceuticals, Inc. | Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions |
| MX2013006040A (es) * | 2010-12-07 | 2013-08-26 | Amira Pharmaceuticals Inc | Antagonistas del receptor de acido lisofosfatidico y su uso en el tratamiento de fibrosis. |
| EA024967B1 (ru) | 2010-12-07 | 2016-11-30 | Амира Фармасьютикалс, Инк. | Полициклический lpaантагонист и его применение |
| JP2014513077A (ja) | 2011-04-05 | 2014-05-29 | アミラ ファーマシューティカルス，インコーポレーテッド | 線維症、疼痛、癌、ならびに呼吸器、アレルギー性、神経系または心血管疾患の治療に有用な３−または５−ビフェニル−４−イルイソキサゾールに基づく化合物 |
| WO2012138648A1 (en) * | 2011-04-06 | 2012-10-11 | Irm Llc | Compositions and methods for modulating lpa receptors |
| KR20140067048A (ko) * | 2011-08-15 | 2014-06-03 | 인터뮨, 인크. | 라이소포스파티드산 수용체 길항제 |
| WO2013085824A1 (en) | 2011-12-04 | 2013-06-13 | Angion Biomedica Corp. | Small molecule anti-fibrotic compounds and uses thereof |
| KR20150011003A (ko) | 2012-06-20 | 2015-01-29 | 에프. 호프만-라 로슈 아게 | Lpar 길항제로서 치환된 피라졸 화합물 |
| CA2869564A1 (en) | 2012-06-20 | 2013-12-27 | F. Hoffmann-La Roche Ag | N-aryltriazole compounds as lpar antagonists |
| AU2013279512A1 (en) | 2012-06-20 | 2014-10-16 | F. Hoffmann-La Roche Ag | N-alkyltriazole compounds as LPAR antagonists |
| US8986704B2 (en) * | 2012-07-06 | 2015-03-24 | Valneva Austria Gmbh | Mutant fragments of OspA and methods and uses relating thereto |
| EP2940013B1 (en) * | 2012-12-28 | 2018-02-21 | Ube Industries, Ltd. | Halogen-substituted heterocyclic compound |
| CA3005811A1 (en) * | 2015-11-20 | 2017-05-26 | Ube Industries, Ltd. | Pharmaceutical composition for treatment or prevention of nash |
-
2015
- 2015-06-26 MX MX2016017371A patent/MX370408B/es active IP Right Grant
- 2015-06-26 ES ES15812460T patent/ES2824801T3/es active Active
- 2015-06-26 AU AU2015281021A patent/AU2015281021B9/en active Active
- 2015-06-26 US US15/321,633 patent/US10023554B2/en active Active
- 2015-06-26 JP JP2016529683A patent/JP6579103B2/ja active Active
- 2015-06-26 CN CN201580035089.8A patent/CN106458964B/zh active Active
- 2015-06-26 KR KR1020177002086A patent/KR102433588B1/ko active IP Right Grant
- 2015-06-26 WO PCT/JP2015/068575 patent/WO2015199234A1/ja active Application Filing
- 2015-06-26 RU RU2017102513A patent/RU2689315C2/ru active
- 2015-06-26 CA CA2953472A patent/CA2953472C/en active Active
- 2015-06-26 EP EP15812460.2A patent/EP3162801B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016030018A2 (pt) | 2017-08-22 |
| CN106458964B (zh) | 2019-11-22 |
| US10023554B2 (en) | 2018-07-17 |
| ES2824801T3 (es) | 2021-05-13 |
| CA2953472C (en) | 2022-08-02 |
| MX370408B (es) | 2019-12-11 |
| CN106458964A (zh) | 2017-02-22 |
| AU2015281021B2 (en) | 2019-03-14 |
| EP3162801A1 (en) | 2017-05-03 |
| KR102433588B1 (ko) | 2022-08-19 |
| JP6579103B2 (ja) | 2019-09-25 |
| AU2015281021B9 (en) | 2019-03-28 |
| EP3162801B1 (en) | 2020-07-22 |
| MX2016017371A (es) | 2017-05-01 |
| CA2953472A1 (en) | 2015-12-30 |
| RU2017102513A (ru) | 2018-07-27 |
| EP3162801A4 (en) | 2018-01-24 |
| AU2015281021A1 (en) | 2017-01-19 |
| JPWO2015199234A1 (ja) | 2017-04-27 |
| WO2015199234A1 (ja) | 2015-12-30 |
| KR20170016988A (ko) | 2017-02-14 |
| US20170158663A1 (en) | 2017-06-08 |
| RU2689315C2 (ru) | 2019-05-27 |
| BR112016030018A8 (pt) | 2023-05-09 |